companies developing glp 1 drugs GLP-1 Agonists Weight Loss Market Report, 2025-2030 GLP-1 Safety Check - National
Description
The Affordable Care Act does not require insurers to cover obesity medications
In addition to the savings many GLP-1 users receive thanks to their insurance coverage, lifestyle changes brought on by use of GLP-1 medications have created additional savings for many
Two participants reported obsession with food prior to starting a GLP-1 receptor agonist, one of whom was diagnosed with BED
Metformin is not FDA-approved for weight loss.
Discussing genetic predisposition results with your provider supports a more personalized conversation about which non-GLP-1 agent may warrant consideration first
Read Next Disclaimer: This content is for educational purposes only
